Literature DB >> 30444761

Advances in fetal echocardiography: myocardial deformation analysis, cardiac MRI and three-dimensional printing.

Sarah Chambers Gurson1.   

Abstract

PURPOSE OF REVIEW: Advances in ultrasound technology have led to new ways of evaluating cardiac function and structure, including myocardial deformation imaging (strain and strain rate), cardiac MRI and three-dimensional (3D) printing. As ultrasound technology has improved, it has become possible to use these modalities to evaluate the fetal heart. This article will review some of the more recent developments in applying these techniques to the evaluation of fetal cardiac structure and function. RECENT
FINDINGS: Myocardial deformation analyses have led to the establishment of normative values for strain and strain rate in the fetal heart and have also been used to evaluate fetal heart function in both fetal disease states and maternal disease states. Technological advances in MRI technology, 3D imaging and 3D printing have opened up new methods of evaluating fetal structural heart disease.
SUMMARY: A deeper understanding of the subtleties of myocardial dysfunction in various fetal and maternal disease states may elucidate the pathophysiology involved and lead to new treatment and/or counseling paradigms that may ultimately affect outcome. Similarly, the ability to image the fetal heart in new ways, including fetal MRI and 3D printing, could potentially change fetal counseling techniques and prenatal planning.

Entities:  

Mesh:

Year:  2019        PMID: 30444761     DOI: 10.1097/HCO.0000000000000584

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  1 in total

1.  Three-Dimensional Printing of Fetal Models of Congenital Heart Disease Derived From Microfocus Computed Tomography: A Case Series.

Authors:  Camilla Sandrini; Claudio Lombardi; Andrew I U Shearn; Maria Victoria Ordonez; Massimo Caputo; Francesca Presti; Giovanni Battista Luciani; Lucia Rossetti; Giovanni Biglino
Journal:  Front Pediatr       Date:  2020-01-21       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.